Tuesday Aug 31, 2021
SCCM Pod-440 Optimal Sedation in Patients Who Receive Neuromuscular Blocking Agent Infusions for ARD
Two previously published trials (ARDS et Curarisation Systematique and Reevaluation of Systemic Early Neuromuscular Blockade) presented equivocal evidence on the effect of neuromuscular blocking agent infusions in patients with acute respiratory distress syndrome.
Version: 20241125
No comments yet. Be the first to say something!